https://www.marketscreener.com/quote/stock/SORRENTO-THERAPEUTICS-INC-14708339/news/Sorrento-Announces-Enrollment-of-First-Subject-in-Brazil-Phase-2-Study-of-COVI-MSC-for-Treatment-of-36312414/?utm_source=telegram&utm_medium=social&utm_campaign=share